Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Change in Cash: 2020-2024

Historic Change in Cash for Therapeutics (RAPT) over the last 5 years, with Dec 2024 value amounting to $131.8 million.

  • Therapeutics' Change in Cash rose 2080.40% to $131.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $122.3 million, marking a year-over-year increase of 1332.92%. This contributed to the annual value of $122.3 million for FY2024, which is 1332.92% up from last year.
  • According to the latest figures from Q4 2024, Therapeutics' Change in Cash is $131.8 million, which was up 15,918.83% from $823,000 recorded in Q3 2024.
  • Therapeutics' 5-year Change in Cash high stood at $131.8 million for Q4 2024, and its period low was -$62.6 million during Q2 2020.
  • Over the past 3 years, Therapeutics' median Change in Cash value was $4.2 million (recorded in 2023), while the average stood at $12.1 million.
  • Per our database at Business Quant, Therapeutics' Change in Cash crashed by 867.16% in 2021 and then surged by 4,337.88% in 2022.
  • Therapeutics' Change in Cash (Quarterly) stood at $4.7 million in 2020, then tumbled by 867.16% to -$36.0 million in 2021, then surged by 131.25% to $11.2 million in 2022, then slumped by 159.23% to -$6.7 million in 2023, then surged by 2,080.40% to $131.8 million in 2024.
  • Its last three reported values are $131.8 million in Q4 2024, $823,000 for Q3 2024, and -$8.2 million during Q2 2024.